Immunotherapy may improve functional cure of chronic hepatitis B / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
;
(6): 261-268, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-709048
ABSTRACT
Currently, clinical antiviral therapies for chronic hepatitis B virus (HBV) infection can efficiently control HBV replication.However, it remains difficult to achieve HBsAg clearance and sustains off-therapy, that is the functional cure of chronic hepatitis B ( CHB) in most of patients.Host immune responses play critical roles in HBV clearance and HBV infection control by activating innate and adaptive immune responses, resulting in improving the functional cure rate of patients with CHB.This article reviews the recent advances in immunology studies related to functional cure of CHB.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Clinical Infectious Diseases
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS